Genomtec S.A.

Legal Proceedings Report • Feb 12, 2024

TheExecutive Board of Genomtec S.A. ("Company", "Issuer") registered inWroclaw, Poland, hereby reports that today The Company has learned abouta positive decision of the Canadian Intellectual Property Officegranting the Company patent protection for an invention entitled _quot;Amethod of detecting genetic material in a biological sample and a devicefor its implementation_quot;. Granting a patent is conditional on the Issuerpaying the required official fees for which the Management Board ofGenomtec S.A. has agreed.

Theinvention covers the key technical solutions related to the proprietarycontactless heating and temperature detection system developed for POCTplatforms, including Genomtec ID.TheIssuer informs that this is the first patent granted by the CanadianIntellectual Property Office and the eleventh patent received by theCompany. The Issuer is pending over twenty patent applications all overthe world.

Inthe opinion of the Management Board, a high level of intellectualproperty protection will also provide the Company with an appropriatenegotiating position before signing commercial agreements with selectedpartners in the scope of implementing the commercialization strategy.

Patentproceedings are aimed at securing key interests and are in line with theIssuer's development strategy, which includes building a portfolio ofintellectual property rights. POCT diagnostics using the Genomtec IDplatform is the key area of the Issuer's operations. For these reasons,in the opinion of the Management Board, this information meets thecriteria of confidential information within the meaning of Art. 7 sec. 1MAR.